CMV pp72 Antibodies

Santa Cruz Biotechnology offers a broad range of CMV pp72 Antibodies for research focused on understanding cytomegalovirus (CMV) protein pp72. CMV pp72 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CMV pp72 protein is crucial for viral replication and assembly, playing a significant role in the pathogenesis of CMV infections. Understanding CMV pp72 function is essential for developing therapeutic strategies against CMV-related diseases, particularly in immunocompromised patients. Research on CMV pp72 can provide insights into viral-host interactions and the immune response to CMV. Investigating CMV pp72 expression patterns helps reveal mechanisms of viral infection and potential therapeutic targets. Monitoring CMV pp72 activity enables researchers to evaluate antiviral treatment efficacy and disease progression. Studying CMV pp72 localization during different stages of infection enhances knowledge of viral life cycles. Santa Cruz Biotechnology monoclonal antibodies for CMV pp72 support cutting-edge research advancing our understanding of CMV pathogenesis and potential treatments.